ADORA2A is thought to provide a protective effect against the development of pulmonary hypertension (85), another clinical phenotype that presents in some ROHHAD individuals consequent to recurrent low oxygen due to inadequately managed hypoventilation (5, 86). Here, ADORA2A is linked to pulmonary arterial hypertension.